{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T02:47:31Z","timestamp":1764038851242,"version":"3.45.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024YFFK0388"],"award-info":[{"award-number":["2024YFFK0388"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jacl.2025.06.024","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:16:50Z","timestamp":1751537810000},"page":"1355-1363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of fatty acid desaturase 1 (FADS1) on chronic kidney disease via very low-density lipoprotein: A drug target\u2013related mediation Mendelian randomization study"],"prefix":"10.1016","volume":"19","author":[{"given":"Yongdi","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manrong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxue","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6709-5591","authenticated-orcid":false,"given":"Wanxin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.06.024_bib0001","doi-asserted-by":"crossref","unstructured":"KDIGO 2021, Clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 99, S1-S87, doi:10.1016\/j.kint.2020.11.003 (2021).","DOI":"10.1016\/j.kint.2020.11.003"},{"key":"10.1016\/j.jacl.2025.06.024_bib0002","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.jacl.2025.06.024_bib0003","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrneph.2016.163","article-title":"The global burden of chronic kidney disease: estimates, variability and pitfalls","volume":"13","author":"Glassock","year":"2017","journal-title":"Nature Rev Nephrol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nature Rev Nephrol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0005","first-page":"11","article-title":"Lipid accumulation and chronic kidney disease","author":"Gai","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jacl.2025.06.024_bib0006","first-page":"23","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2025.06.024_bib0007","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","article-title":"Genome-wide characterization of circulating metabolic biomarkers","volume":"628","author":"Karjalainen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2025.06.024_bib0008","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ng.2982","article-title":"An atlas of genetic influences on human blood metabolites","volume":"46","author":"Shin","year":"2014","journal-title":"Nature Genet"},{"key":"10.1016\/j.jacl.2025.06.024_bib0009","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1038\/s41467-019-12703-7","article-title":"A comprehensive study of metabolite genetics reveals strong pleiotropy and heterogeneity across time and context","volume":"10","author":"Gallois","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacl.2025.06.024_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/j.jacl.2025.06.024_bib0011","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ (Clin Res ed.)"},{"key":"10.1016\/j.jacl.2025.06.024_bib0012","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/db23-0564","article-title":"Therapeutic targets for diabetic kidney disease: proteome-wide mendelian randomization and colocalization analyses","volume":"73","author":"Zhang","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2025.06.024_bib0013","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2022.05.041","article-title":"Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function","volume":"80","author":"Rosoff","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0014","article-title":"A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study","volume":"383","author":"Woolf","year":"2023","journal-title":"BMJ (Clin Res ed.)"},{"key":"10.1016\/j.jacl.2025.06.024_bib0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0016","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2025.06.024_bib0017","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nature genetics"},{"key":"10.1016\/j.jacl.2025.06.024_bib0018","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacl.2025.06.024_bib0019","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/annrheumdis-2017-212935","article-title":"Metabolic pathways and immunometabolism in rare kidney diseases","volume":"77","author":"Grayson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacl.2025.06.024_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093138","article-title":"Dietary lipids and dyslipidemia in chronic kidney disease","volume":"13","author":"Kochan","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jacl.2025.06.024_bib0021","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","article-title":"Lipid management in patients with chronic kidney disease","volume":"14","author":"Ferro","year":"2018","journal-title":"Nature rev Nephrol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0022","article-title":"Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL)","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2025.06.024_bib0023","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.06.024_bib0024","doi-asserted-by":"crossref","first-page":"34420","DOI":"10.1074\/jbc.M611289200","article-title":"Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization","volume":"282","author":"Chen","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2025.06.024_bib0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12944-020-01386-5","article-title":"The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome","volume":"19","author":"Lee","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2025.06.024_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103090","article-title":"The reelin receptors apolipoprotein E receptor 2 (ApoER2) and VLDL receptor","volume":"19","author":"Dlugosz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2025.06.024_bib0027","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1523-1755.2001.00478.x","article-title":"Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome","volume":"59","author":"Shearer","year":"2001","journal-title":"Kidney int"},{"key":"10.1016\/j.jacl.2025.06.024_bib0028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-981-19-0394-6_9","article-title":"Cholesterol metabolism in chronic kidney disease: physiology, pathologic mechanisms, and treatment","volume":"1372","author":"Pan","year":"2022","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0029","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41581-021-00488-2","article-title":"Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease","volume":"18","author":"Baek","year":"2022","journal-title":"Nature rev Nephrol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130317","article-title":"Increased lipogenesis and impaired \u03b2-oxidation predict type 2 diabetic kidney disease progression in American Indians","volume":"4","author":"Afshinnia","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacl.2025.06.024_bib0031","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2012.07.049","article-title":"Effects of fibrates in kidney disease: a systematic review and meta-analysis","volume":"60","author":"Jun","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0032","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41419-020-2457-5","article-title":"FADS1 promotes the progression of laryngeal squamous cell carcinoma through activating AKT\/mTOR signaling","volume":"11","author":"Zhao","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jacl.2025.06.024_bib0033","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1039\/D2FO00246A","article-title":"FADS1 overexpression promotes fatty acid synthesis and triacylglycerol accumulation via inhibiting the AMPK\/SREBP1 pathway in goat mammary epithelial cells","volume":"13","author":"Huang","year":"2022","journal-title":"Food Funct"},{"key":"10.1016\/j.jacl.2025.06.024_bib0034","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.kint.2022.01.014","article-title":"Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"101","author":"Rhee","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacl.2025.06.024_bib0035","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/s41467-023-37590-x","article-title":"FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer","volume":"14","author":"Xu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacl.2025.06.024_bib0036","doi-asserted-by":"crossref","first-page":"32433","DOI":"10.1073\/pnas.2006828117","article-title":"Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer","volume":"117","author":"Lee","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jacl.2025.06.024_bib0037","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12672-025-02255-2","article-title":"FADS1, a lipid metabolism-related diagnostic biomarker in KIRC","volume":"16","author":"Yang","year":"2025","journal-title":"Discover Oncol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181485","article-title":"The role of a FADS1 polymorphism in the association of fatty acid blood levels, BMI and blood pressure in young children-analyses based on path models","volume":"12","author":"Wolters","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.jacl.2025.06.024_bib0039","doi-asserted-by":"crossref","first-page":"27531","DOI":"10.1038\/s41598-024-78294-6","article-title":"Cardiometabolic risk factors are affected by interaction between FADS1 rs174556 variant and dietary vegetable oils in patients with diabetes: a randomized controlled trial","volume":"14","author":"Fallah","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacl.2025.06.024_bib0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jacc.2022.06.007","article-title":"Interpreting the clinical implications of drug-target mendelian randomization studies","volume":"80","author":"Ference","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.06.024_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/AITC201506020","article-title":"Chronic kidney disease","volume":"162","author":"Drawz","year":"2015","journal-title":"Ann Int Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742500340X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742500340X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T02:23:50Z","timestamp":1764037430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742500340X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S193328742500340X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.024","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of fatty acid desaturase 1 (FADS1) on chronic kidney disease via very low-density lipoprotein: A drug target\u2013related mediation Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}